Financial Summary (All financials)
| In millions, except per share items | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| Revenues | -0.1 | 9.6 | -3.0 | -1.9 | -7.3 | -1.5 | 0.0 |
| Revenue growth | -100.7% | -416.7% | 57.7% | -73.9% | 385.1% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | -0.1 | 9.6 | -3.0 | -1.9 | -7.3 | -1.5 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Research and development | 53.4 | 24.9 | 47.1 | 87.6 | 141.4 | 134.8 | 76.6 |
| General and administrative | 18.2 | 17.3 | 22.1 | 39.5 | 71.9 | 45.7 | 56.5 |
| EBIT | -71.6 | -32.6 | -72.2 | -128.9 | -220.7 | -182.0 | -133.2 |
| EBIT margin | 108527.3% | -341.4% | 2391.2% | 6736.3% | 3008.6% | 12037.8% | |
| Pre-tax income | -71.6 | -32.6 | -72.2 | -128.9 | -220.7 | -182.0 | -133.2 |
| Income taxes | 0.3 | -0.2 | 0.4 | 0.1 | 0.9 | -1.1 | 0.0 |
| Tax rate | | 0.6% | | | | 0.6% | 0.0% |
| Net income | -71.9 | -32.4 | -72.6 | -129.1 | -221.6 | -181.0 | -133.1 |
| Net margin | 108939.4% | -338.9% | 2404.8% | 6743.2% | 3021.2% | 11967.7% | |
| |
| Diluted EPS | ($0.98) | ($0.62) | ($2.93) | ($8.02) | ($16.51) | ($1.82) | ($1.41) |
| Shares outstanding (diluted) | 73.2 | 52.2 | 24.8 | 16.1 | 13.4 | 99.2 | 94.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|